Burning Rock Biotech's loss under IFRS for 6M 2021 was CN¥375.076 million, up three times from CN¥123.627 million in the previous year. Revenue increased 34.2% to CN¥233.902 million from CN¥174.3 million a year earlier.
Burning Rock Biotech's loss under IFRS for 6M 2021 was CN¥375.076 million, up three times from CN¥123.627 million in the previous year. Revenue increased 34.2% to CN¥233.902 million from CN¥174.3 million a year earlier. 
ir.brbiotech.com
English (US) 